Related Experiment Video
Updated: Sep 10, 2026

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
Published on: January 22, 2018
Targeted therapy for advanced gastric cancer: A review of current status and future prospects
Ozkan Kanat1, Bert O'Neil1, Safi Shahda1
1Ozkan Kanat, Department of Medical Oncology, Uludag University faculty of Medicine, 16059 Bursa, Turkey.
Abstract:
In the West in particular, the vast majority of gastric cancer (GC) patients present with advanced-stage disease. Although combination chemotherapy is still the most important component of treatment for these patients, it confers a modest survival advantage. Recently, increased knowledge of the key molecular signaling pathways involved in gastric carcinogenesis has led to the discovery of specific molecular-targeted therapeutic agents. Some of these agents such as trastuzumab and ramucirumab have changed the treatment paradigm for this disease. In this paper, we will summarize the current clinical status of targeted drug therapy in the management of GC.
Insights
Advanced gastric cancer (GC) treatment is improving with targeted drug therapies. Agents like trastuzumab and ramucirumab offer new hope for patients with advanced disease, changing standard treatment protocols.
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Background:
- Gastric cancer (GC) predominantly presents at advanced stages in Western populations.
- Current combination chemotherapy offers limited survival benefits for advanced GC.
- Recent advances reveal key molecular pathways driving gastric carcinogenesis.
Purpose of the Study:
- To review the clinical status of targeted drug therapies for gastric cancer management.
- To highlight novel therapeutic agents impacting GC treatment paradigms.
Main Methods:
- Literature review of clinical trials and studies on targeted therapies in GC.
- Analysis of molecular signaling pathways implicated in gastric cancer development.
- Evaluation of the efficacy and impact of specific targeted agents.
Main Results:
- Targeted agents like trastuzumab and ramucirumab have demonstrated significant clinical efficacy.
- These targeted therapies are altering the standard treatment protocols for advanced GC.
- Increased understanding of molecular pathways facilitates the development of new targeted drugs.
Conclusions:
- Targeted drug therapy represents a significant advancement in managing advanced gastric cancer.
- Personalized medicine approaches utilizing targeted agents are becoming crucial in GC treatment.
- Continued research into molecular pathways will likely yield further therapeutic innovations for GC.
More Related Videos
08:59Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
Published on: December 11, 2017
06:21Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer
Published on: May 10, 2024
Related Concept Videos
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Treatment Resistent Cancers
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...